NEJM Group partners with GetFTR to improve access to trusted medical research

The collaboration will make NEJM Group content easier to discover and access across research platforms and tools, while helping readers connect with full-text content from participating publishers.

NEJM Group products include the New England Journal of Medicine, NEJM Evidence, NEJM AI, and NEJM Catalyst, all published by the Massachusetts Medical Society.  NEJM is the world’s most cited general medical journal, with influential research that informs clinical practice, advances medical knowledge and supports evidence-based healthcare globally.

As researchers and healthcare professionals increasingly discover information through a wide range of research tools, AI assistants and other online resources, clear information about full-text availability and straightforward access to trusted sources are more important than ever.

Through the partnership, researchers using discovery services and tools that have integrated with GetFTR will be able to see clear indicators of their access to NEJM Group content, alongside smartlinks to the authoritative full text. These benefits will also extend to users of GetFTR’s free Browser Extension, which provides access indicators and links to full text on any website citing academic content.

At the same time,GetFTR functionality will be incorporated into article references on its own journals platform, helping users identify and access relevant research from other participating publishers.

For publishers, GetFTR creates opportunities to reach readers through an expanding range of research and discovery tools. For libraries and institutions, it helps make subscribed, open access and free content more visible and accessible across the platforms their researchers use, supporting greater use of their collections.

With NEJM participating as both an authoritative source of medical evidence and a research platform demonstrates how collaboration across the scholarly community can help create a more connected and accessible research experience.

“Welcoming NEJM and the entire portfolio to GetFTR is a significant milestone” said Heather Staines, Head of Business Development. “As one of the most respected names in medical publishing, NEJM brings both influential research content and a commitment to helping researchers and healthcare professionals access the evidence they need”.

“As medical information is increasingly cited in AI-enabled tools, it’s important that readers can link back to the authoritative evidence source,” said NEJM Group Vice President and Chief Publishing Officer, David Sampson. “GetFTR ensures readers using these tools can connect to the version of record when NEJM Group journals are cited and supports our mission to make trusted medical knowledge available wherever the research journey begins.”

The collaboration further strengthens GetFTR’s growing community of publishers and research platforms, working together to improve how scholarly content is discovered and accessed.

ENDS

MORE NEWS

iStock
iStock
iStock
Freepix/Magnific
ResearchGate integrates with GetFTR
Freepik / Magnific